About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

US President Trump: The economic data is very good.

2025-09-26

US President Trump: The economic data is very good.

Other News
2025-09-26

New York silver futures hit $46 an ounce, up 1.96% on the day.

New York silver futures hit $46 an ounce, up 1.96% on the day.
2025-09-26

Stock News: 1. CSPC Pharmaceutical Group (01093.HK): Lencaneluzumab Injection Receives Clinical Trial Approval in China. 2. Xpeng Motors (09868.HK) Issues 3.2472 million Class A Ordinary Shares Under Share Plan. 3. Fuyao Glass (03606.HK) Will Pay an

Stock News: 1. CSPC Pharmaceutical Group (01093.HK): Lencaneluzumab Injection Receives Clinical Trial Approval in China. 2. Xpeng Motors (09868.HK) Issues 3.2472 million Class A Ordinary Shares Under Share Plan. 3. Fuyao Glass (03606.HK) Will Pay an Interim Dividend of HK$0.986712 Per Share on November 13. 4. Alibaba (09988.HK): Grants the Board of Directors Authorization to Issue 10% of the Company's Ordinary Shares. 5. Guoquan (02517.HK) Plans to Use Up to HK$100 Million to Further Repurchase H Shares. 6. Jihong Holdings (02603.HK) Expects Net Profit attributable to Parent Company to Increase by 55%–65% Year-on-Year in the First Three Quarters. 7. New World Development (00017.HK) Secures HK$5.9 Billion in Loan Financing, Secured by the Victoria Harbour Cultural Centre Property. 8. A subsidiary of Tianjin Port Development (03382.HK) plans to acquire a 5% stake in Eurasia International for RMB 95.403 million. 9. Times China Holdings (01233.HK): The final deadline for the restructuring support agreement has been extended to December 31. 10. Tianjin Port Development (03382.HK) plans to acquire a 40% stake in Alliance International for RMB 723 million, increasing its stake to 100%. 11. New World Department Store China (00825.HK) announced its annual results: net profit of HK$25.285 million, an 89.91% year-on-year increase. 12. Shanghai Pharmaceuticals (02607.HK): Shanghai SIIC Yangtze River Delta transferred a 40% stake in Shanghai Pharmaceuticals Group to Shanghai SIIC for approximately RMB 6.7215 billion. 13. A subsidiary of Huiyuan Tongchuang Technology (01116.HK) will establish a joint venture with EPS to manufacture phase change energy storage products and promote their industrialization in the Chinese market.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2025 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.

Web Design by YSD